摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Anhalonidin | 529-58-8

中文名称
——
中文别名
——
英文名称
Anhalonidin
英文别名
Anhalonidine;6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinolin-8-ol
Anhalonidin化学式
CAS
529-58-8
化学式
C12H17NO3
mdl
——
分子量
223.272
InChiKey
PRNZAMQMBOFSJY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    161-161.5 °C(Solv: acetone (67-64-1))
  • 沸点:
    313.0±42.0 °C(Predicted)
  • 密度:
    1.123±0.06 g/cm3(Predicted)
  • 保留指数:
    1825;1823.7

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    50.7
  • 氢给体数:
    2
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    acetic acid-(6,7-dimethoxy-1-methyl-3,4-dihydro-[8]isoquinolyl ester) 在 盐酸tin 作用下, 生成 Anhalonidin
    参考文献:
    名称:
    Spaeth, Monatshefte fur Chemie, 1922, vol. 43, p. 478
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Compounds and compositions for treating infection
    申请人:Chepkwony Paul Kiprono
    公开号:US20090069277A1
    公开(公告)日:2009-03-12
    Compounds from 14 Kenyan plants, including from the root of Dovyalis abyssinica and Clutia robusta have been characterized and isolated, and their uses are disclosed.
    来自14种肯尼亚植物的化合物,包括 Dovyalis abyssinica 和 Clutia robusta 的根部已经被鉴定和分离,它们的用途也被公开了。
  • COMPOUNDS AND COMPOSITIONS FOR TREATING INFECTION
    申请人:Chepkwony Paul Kiprono
    公开号:US20120190734A1
    公开(公告)日:2012-07-26
    Compounds from 14 Kenyan plants, including from the root of Dovyalis abyssinica and Clutia robusta have been characterized and isolated, and their uses are disclosed.
    来自14种肯尼亚植物的化合物已经被鉴定和分离,包括来自阿比西尼亚多维亚利斯和强健小簇花的根部,它们的用途已经被披露。
  • SUBSTANCE DELIVERY PLANNING SYSTEM
    申请人:Syqe Medical Ltd.
    公开号:US20220223247A1
    公开(公告)日:2022-07-14
    Some embodiments relate to a method for generating a delivery regimen of at least one active substance to a user, comprising: receiving input including one or both of timed activities to be engaged by the user, timed preferred user experiences; and automatically generating a delivery regimen including at least one of delivery times and amounts of the at least one active substance, based on: (a) estimating at least one of a timing and magnitude of at least one effect expected to be induced by the at least one active substance on the user; and (b) estimating an impact of the at least one effect on the timed activities and/or the timed preferred user experiences.
  • US8067401B2
    申请人:——
    公开号:US8067401B2
    公开(公告)日:2011-11-29
  • US8697660B2
    申请人:——
    公开号:US8697660B2
    公开(公告)日:2014-04-15
查看更多